A population pharmacokinetic-pharmacodynamic model for tenofovir in plasma and rectal tissues of healthy volunteers

被引：0
|
作者：
Jayachandran, P. [1 ]
Garcia-Cremades, M. [1 ]
Anton, P. [3 ]
Hendrix, C. [2 ]
Savic, R. M. [1 ]
机构：
[1] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA
[2] Johns Hopkins Univ, Dept Med, Div Clin Pharmacol, Baltimore, MD USA
[3] Univ Calif Los Angeles, Los Angeles, CA USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2018年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
W-012
引用
收藏
页码：S95 / S95
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetic-Pharmacodynamic Modelling of Biomarker Response to Sitagliptin in Healthy Volunteers
    Kim, Bo-Hyung
    Kim, Sung Eun
    Kang, Dongwoo
    Lim, Kyoung Soo
    Kim, Jung-Ryul
    Jang, In-Jin
    Shin, Sang-Goo
    Yoon, Seo Hyun
    Cho, Joo-Youn
    Yu, Kyung-Sang
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 113 (02) : 113 - 125
  • [22] Pharmacokinetic-pharmacodynamic model of topiramate-induced working memory impairment in healthy volunteers
    Callisto, Samuel P.
    Birnbaum, Angela K.
    Barkley, Christopher M.
    Bathena, Sai Praneeth
    Marino, Susan E.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S98 - S99
  • [23] Population pharmacokinetic-pharmacodynamic modelling of liquid and controlled-release formulations of oxycodone in healthy volunteers
    Ladebo, Louise
    Foster, David J. R.
    Abuhelwa, Ahmad Y.
    Upton, Richard N.
    Kongstad, Kenneth T.
    Drewes, Asbjorn M.
    Christrup, Lona L.
    Olesen, Anne E.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 126 (03) : 263 - 276
  • [24] Population Pharmacokinetic/Pharmacodynamic Model for the Sedative Effects of Flibanserin in Healthy Volunteers
    Iñaki F. Trocóniz
    Katja Boland
    Alexander Staab
    Pharmaceutical Research, 2012, 29 : 1518 - 1529
  • [25] Population Pharmacokinetic/Pharmacodynamic Model for the Sedative Effects of Flibanserin in Healthy Volunteers
    Troconiz, Inaki F.
    Boland, Katja
    Staab, Alexander
    PHARMACEUTICAL RESEARCH, 2012, 29 (06) : 1518 - 1529
  • [26] Metformin and daclatasvir: absence of a pharmacokinetic-pharmacodynamic drug interaction in healthy volunteers
    Smolders, Elise J.
    Colbers, Angela
    de Kanter, Clara T. M. M.
    Velthoven-Graafland, Kirsten
    Wolberink, Leonie T.
    Kolmer, Noor van Ewijk-Beneken
    Drenth, Joost P. H.
    Aarnoutse, Rob E.
    Tack, Cees J.
    Burger, David M.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (10) : 2225 - 2234
  • [27] Pharmacokinetic-Pharmacodynamic Modelling of Opioids in Healthy Human Volunteers. A MiniReview
    Lorenzini, Kuntheavy Ing
    Daali, Youssef
    Dayer, Pierre
    Desmeules, Jules
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 110 (03) : 219 - 226
  • [28] Pharmacokinetic-pharmacodynamic modeling of CNS effects of scopolamine in healthy volunteers.
    Ebert, U
    Oertel, R
    Sickor, S
    Kirch, W
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 189 - 189
  • [29] Pharmacokinetic-pharmacodynamic modeling of the new steroid hypnotic eltanolone in healthy volunteers
    Hering, WJ
    Ihmsen, H
    Langer, H
    Uhrlau, C
    Dinkel, M
    Geisslinger, G
    Schuttler, J
    ANESTHESIOLOGY, 1996, 85 (06) : 1290 - 1299
  • [30] Population pharmacokinetic-pharmacodynamic model of oral fludrocortisone on blood pressure after six days of repeated administration in healthy volunteers
    Laviolle, B.
    Hamitouche, N.
    Bellissant, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 10 - 10
12345